The executive team at ImmunoMet Therapeutics has significant experience in the pharmaceutical and biotechnology industries. Members of the team have served as board members and vice presidents at various companies, including INCON Co., Ltd, Milestone Pharmaceuticals, PDS Biotechnology, and Atrin Pharmaceuticals. The team is also highly educated, with members holding degrees from Carnegie Mellon University and the University of Illinois Urbana-Champaign.
View all